Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,098,319 papers from all fields of science
Search
Sign In
Create Free Account
epiroprim
A trimethoprim analogue and selective inhibitor of microbial dihydrofolate reductase, with antibacterial activity. Epiroprim inhibits the bacterial…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (1)
Trimethoprim
analogs & derivatives
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2002
2002
Interaction Energy Analysis of Nonclassical Antifolates with Pneumocystis carinii Dihydrofolate Reductase
C. Pitts
,
Jian Yin
,
D. Bowen
,
C. J. Maxwell
,
W. Southerland
2002
Corpus ID: 14149874
Abstract: The x-ray structure of the Pneumocystis carinii dihydrofolate reductase (DHFR):trimethoprim:NADPH ternary complex…
Expand
2002
2002
In vivo activity of epiroprim, a dihydrofolate reductase inhibitor, singly and in combination with dapsone, against Mycobacterium leprae.
A. Dhople
International Journal of Antimicrobial Agents
2002
Corpus ID: 22694042
2002
2002
[Preliminary study on isoniazid-epiroprim combination in a tuberculosis murine model].
K. N'guessan
,
M. Dosso
,
+4 authors
Edy
Bulletin de la Société de Pathologie Exotique
2002
Corpus ID: 1947671
The purpose of this study regarding isoniazid-epiroprim's association applied to antituberculosis chemotherapy, carried through…
Expand
2001
2001
Experimental in vitro Efficacy Study on the Interaction of Epiroprim plus Isoniazid against Mycobacterium tuberculosis
M. Dosso
,
L. Ouattara
,
A. Cherif
,
S. Bouzid
,
L. Haller
,
M. Fernex
Chemotherapy
2001
Corpus ID: 30343267
Thirty Mycobacterium tuberculosis strains (8: INH<sup>R</sup>/INH<sup>R</sup>, 12: INH<sup>R</sup>/RIF<sup>S</sup>, 10: INH<sup>S…
Expand
1999
1999
In vitro activity of epiroprim, a dihydrofolate reductase inhibitor, singly and in combination with brodimoprim and dapsone, against Mycobacterium leprae
Dhople Am
1999
Corpus ID: 221587305
Highly Cited
1996
Highly Cited
1996
Antibacterial activities of epiroprim, a new dihydrofolate reductase inhibitor, alone and in combination with dapsone
H. Locher
,
Heidi Schlunegger
,
P. Hartman
,
P. Angehrn
,
R. Then
Antimicrobial Agents and Chemotherapy
1996
Corpus ID: 5895068
Epiroprim (EPM; Ro 11-8958) is a new selective inhibitor of microbial dihydrofolate reductase. EPM displayed excellent activity…
Expand
1996
1996
Efficacy of epiroprim (Ro11-8958), a new dihydrofolate reductase inhibitor, in the treatment of acute Toxoplasma infection in mice.
A. Martínez
,
C. Allegra
,
J. Kovacs
American Journal of Tropical Medicine and Hygiene
1996
Corpus ID: 42123241
Toxoplasma gondii is a major cause of focal encephalitis in patients with acquired immunodeficiency syndrome. Epiroprim, an…
Expand
1996
1996
Simple HPLC Determination of the Concentrations of Epiroprim in the Serum and Brains of Mice
How-sung Lee
,
Hernan R. Chang
,
Y. Khoo
The Journal of pharmacy and pharmacology
1996
Corpus ID: 9117896
Epiroprim, an analogue of trimethoprim, has been shown to potentiate the efficacy of dapsone in experimental parasitic infections…
Expand
1994
1994
Activity of epiroprim (Ro 11-8958), a dihydrofolate reductase inhibitor, alone and in combination with dapsone against Toxoplasma gondii
H. R. Chang
,
D. Arsenijevic
,
R. Comte
,
A. Polak
,
R. Then
,
J. Pechère
Antimicrobial Agents and Chemotherapy
1994
Corpus ID: 23472509
We examined the effect of epiroprim (Ro 11-8958), a dihydrofolate reductase inhibitor, alone and in combination with dapsone…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE